Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Sunday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Up 0.8 %

Shares of ENZ stock opened at $0.49 on Friday. The stock has a fifty day moving average of $0.55 and a two-hundred day moving average of $0.85. Enzo Biochem has a 1 year low of $0.41 and a 1 year high of $1.30.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Monday, March 17th. The medical research company reported ($0.02) earnings per share (EPS) for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%. The business had revenue of $7.33 million during the quarter.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC acquired a new position in shares of Enzo Biochem in the 4th quarter valued at $35,000. Lepercq Multi Asset Fund acquired a new stake in shares of Enzo Biochem during the 4th quarter valued at about $88,000. BBR Partners LLC bought a new stake in Enzo Biochem in the third quarter valued at about $112,000. Wittenberg Investment Management Inc. raised its position in Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the period. Institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.